Our high-throughput sequencing facility maintains two of the latest Illumina HiSeq 4000 systems, which we operate in conjunction with three HiSeq 2500’s and two Illumina Miseq systems. Both of these platforms utilise Illumina's proven and widely adopted reversible terminator-based sequencing-by-synthesis chemistry, in combination with innovative scanning technology.
Based on Illumina's BeadArray technology, Agena's MassArray system and the Affymetrix GeneTitan microarray platform, we offer a range of applications to support small-scale and high-throughput studies. Alongside genome-wide association studies and follow-up validation work, we can also perform specific genotyping, methylation assays and gene expression analysis.
The Oxford Genomics Centre is a leading centre for the generation and statistical analysis of genomic data. Our aim is to couple cutting-edge research into the genetic basis of complex disease with the development of statistical methodology and computational tools to help researchers interpret their data.
Scientists from the Wellcome Trust Centre for Human Genetics (WTCHG) have used Oxford Nanopore Technologies MinION sequencing devices to sequence two human DNA samples, in an exploration of the capabilities of the pocket-sized, USB-powered sequencing devices. Oxford Nanopore Technologies (https://nanoporetech.com/) has developed sequencing and ...